 |
|
|
| |
Twelve Weeks of Ledipasvir/Sofosbuvir All-oral Regimen for Patients with Chronic Hepatitis C Genotype 2 Infection:
Integrated Analysis of Three Clinical Studies
|
| |
| |
Reported by Jules Levin
APASL 2018 March 14-18, Aerocity, New Dehli
Yasuhiro Asahina1, Chun-Jen Liu2, Edward Gane3, Yoshito Itoh4, Norifumi Kawada5, Yoshiyuki Ueno6, Chen-Yu Wang7, Joe Llewellyn7, Anu Osinusi7, Jenny Svarovskaia7, Hongmei Mo7, Gerald Crans7, Wan-Long Chuang8, Pei-Jer Chen2, Nobuyuki Enomoto9
1Tokyo Medical and Dental University, Tokyo, Japan, 2National Taiwan University Hospital, Taipei, Taiwan, 3Auckland Clinical Studies Limited, Auckland, New Zealand, 4Kyoto Prefectural University of Medicine, Kyoto, Japan, 5Osaka City University, Osaka, Japan, 6Yamagata University, Yamagata, Japan, 7Gilead Sciences, Foster City, USA, 8Kaohsiuang Medical University Hospital, Kaohsiung Taiwan, 9University of Yamanashi, Yamanashi, Japan
|
| |
|
|
|
|
|
